Viewing Study NCT01035502


Ignite Creation Date: 2025-12-25 @ 4:05 AM
Ignite Modification Date: 2025-12-26 @ 3:00 AM
Study NCT ID: NCT01035502
Status: COMPLETED
Last Update Posted: 2013-09-27
First Post: 2009-12-15
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of Elacytarabine (CP-4055) Plus Idarubicin as Second Course Remission-Induction Therapy in Patients With Acute Myeloid Leukaemia
Sponsor: Clavis Pharma
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module